| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Common Stock | Options Exercise | $175,050 | +5,000 | +6.7% | $35.01 | 79,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $154,700 | +5,000 | +6.3% | $30.94 | 84,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $94,900 | +5,000 | +5.9% | $18.98 | 89,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $21,750 | +5,000 | +5.6% | $4.35* | 94,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $100,880 | +6,500 | +6.9% | $15.52 | 101,337 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $140,550 | +7,500 | +7.4% | $18.74 | 108,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $59,350 | +5,000 | +4.6% | $11.87 | 113,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Options Exercise | $59,550 | +5,000 | +4.4% | $11.91 | 118,837 | 09 Feb 2022 | Direct | |
| transaction | FCX | Common Stock | Sale | $1,911,540 | -44,000 | -37% | $43.44 | 74,837 | 09 Feb 2022 | Direct | F2, F3 |
| holding | FCX | Common Stock | 1,971 | 09 Feb 2022 | By 401(k) | F1 | |||||
| holding | FCX | Common Stock | 3,785 | 09 Feb 2022 | By Spouse Through GRAT | ||||||
| holding | FCX | Common Stock | 3,785 | 09 Feb 2022 | Through GRAT |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -100% | $0.000000* | 0 | 09 Feb 2022 | Common Stock | 5,000 | $35.01 | Direct | F4 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -100% | $0.000000* | 0 | 09 Feb 2022 | Common Stock | 5,000 | $30.94 | Direct | F4 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -50% | $0.000000 | 5,000 | 09 Feb 2022 | Common Stock | 5,000 | $18.98 | Direct | F4 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -13% | $0.000000 | 33,500 | 09 Feb 2022 | Common Stock | 5,000 | $4.35 | Direct | F4 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -6,500 | -39% | $0.000000 | 10,000 | 09 Feb 2022 | Common Stock | 6,500 | $15.52 | Direct | F4 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -7,500 | -30% | $0.000000 | 17,500 | 09 Feb 2022 | Common Stock | 7,500 | $18.74 | Direct | F5 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -14% | $0.000000 | 30,000 | 09 Feb 2022 | Common Stock | 5,000 | $11.87 | Direct | F5 |
| transaction | FCX | Options (right to buy) | Options Exercise | $0 | -5,000 | -11% | $0.000000 | 40,000 | 09 Feb 2022 | Common Stock | 5,000 | $11.91 | Direct |
| Id | Content |
|---|---|
| F1 | Based on plan statement as of December 31, 2021. |
| F2 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $43.4200 - $43.4850. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F3 | Amount beneficially owned includes 59,999 RSUs. |
| F4 | 25% exercisable on the date indicated and 25% exercisable on each of the next three anniversaries thereof. |
| F5 | 33.3% exercisable on the date indicated and on each of the next two anniversaries thereof. |